NCT01334567 Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan Status COMPLETED Phase PHASE2
NCT01333813 Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children Status COMPLETED Phase PHASE4
NCT01300234 Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB) Status COMPLETED Phase PHASE3
NCT01298037 HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01259453 Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules Status COMPLETED Phase PHASE4
NCT01248884 Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) Status COMPLETED Phase PHASE2
NCT01203319 The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines Status COMPLETED Phase PHASE2/PHASE3
NCT01182311 Duration of Long-term Immunity After Hepatitis B Virus Immunization Status COMPLETED Phase N/A
NCT01177722 A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants Status COMPLETED Phase PHASE3
NCT01171989 Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose Status COMPLETED Phase PHASE2
NCT01163240 Epidemiological Study in Children and Adolescents With Chronic Hepatitis B Status COMPLETED Phase N/A
NCT01146808 Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver Status COMPLETED Phase PHASE1/PHASE2
NCT01139203 Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation Status UNKNOWN Phase NA
NCT01138098 Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children Status COMPLETED Phase PHASE4
NCT01131065 Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients Status COMPLETED Phase PHASE3